New study shows how bacteria adapted a virus-derived injection system to recognize and attach to many different types of ...
A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains ...
StockStory.org on MSN

3 growth stocks set to flourish

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
From life-saving vaccines to advanced cancer therapies, biopharmaceuticals are quietly transforming modern medicine. Made ...
A new nasal spray vaccine could stop bird flu at the door — blocking infection, reducing spread, and helping head off the next pandemic.
Quadruplet regimen demonstrated significantly deeper and more durable responses, higher MRD negativity and improved progression-free survival versus a standard of care?
An experimental drug custom-made to target the genetic mutations of individual tumors showed promise in treating aggressive ...
The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...
Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or COVID vaccine injuryParticipants to include people ...
I don’t know about you, but I’ve always preferred making my own antibodies. Why outsource it? It’s so handy letting my own body do the work of fighting infections while I’m writing articles or ...